drugset / Trial / NCT00055601

Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer

NCT00055601 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. It is not yet known which regimen of combination chemotherapy plus radiation therapy with or without surgery is more effective in treating bladder cancer. PURPOSE: Randomized phase II trial to study the effectiveness of two combination chemotherapy regimens and radiation therapy with or without radical cystectomy in treating patients who have stage II or stage III bladder cancer.

Timeline

Start
2002-12
Primary completion
2010-10
Completion
2018-05-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 50 mg/m2 Intravenous
Subject fluorouracil Small molecule 400 mg/m2 Intravenous
Background Cisplatin Other / unclassified 35 mg/m2 Intravenous
Background Gemcitabine Small molecule 1000 mg/m2 Intravenous